Furthermore, included infants—both in the intervention arm and control arm—who may be sick and need hospitalization for any illnesses will receive standard care treatment at HLH, including study-funded optimal assessment of a potential infection with blood culture and CRP analyses (ancillary care). The gene discussed is CRP; the disease is hemophagocytic syndrome.